Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | Dasatinib-CA-8PAP | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 1 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
LFQ
|
|||||
Competitor Name | Dasatinib | Competitor Info | ||||
Competitor Concentration | 20 uM | |||||
In Vivo Experiment Model | Model Type |
|
Cell lysate | |||
Derived Tissue |
|
Peripheral blood | ||||
Disease Model | Chronic myeloid leukemia [ICD-11:2A20] | |||||
Model Name | Human chronic myeloid leukemia cell lysate (K562) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03989 | Tyrosine-protein kinase Tec (TEC) | 23.0 | ||||
LDTP03944 | Tyrosine-protein kinase CSK (CSK) | 8.8 | ||||
LDTP02824 | Ribosyldihydronicotinamide dehydrogenase [quinone] (NQO2) | 8.0 | ||||
LDTP14075 | AFG3-like protein 2 (AFG3L2) | 6.0 | ||||
LDTP06547 | Mitogen-activated protein kinase 14 (MAPK14) | 5.0 | ||||
LDTP04689 | Adenosine kinase (ADK) | 4.8 | ||||
LDTP10930 | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (PKMYT1) | 4.2 | ||||
LDTP04552 | Biliverdin reductase A (BLVRA) | 4.0 | ||||
LDTP03198 | Ferrochelatase, mitochondrial (FECH) | 4.0 | ||||
LDTP00400 | Torsin-1B (TOR1B) | 4.0 | ||||
LDTP01283 | U5 small nuclear ribonucleoprotein 200 kDa helicase (SNRNP200) | 4.0 | ||||
LDTP02560 | Breakpoint cluster region protein (BCR) | . | ||||
LDTP00497 | Cyclin-G-associated kinase (GAK) | . | ||||
LDTP04631 | Ephrin type-B receptor 4 (EPHB4) | . | ||||
LDTP05554 | Epithelial discoidin domain-containing receptor 1 (DDR1) | . | ||||
LDTP06547 | Mitogen-activated protein kinase 14 (MAPK14) | . | ||||
LDTP02638 | Proto-oncogene tyrosine-protein kinase Src (SRC) | . | ||||
LDTP00751 | Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) | . | ||||
LDTP01784 | Tyrosine-protein kinase ABL1 (ABL1) | . | ||||
LDTP05478 | Tyrosine-protein kinase BTK (BTK) | . | ||||
LDTP02139 | Tyrosine-protein kinase Fyn (FYN) | . |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP01204 | Large neutral amino acids transporter small subunit 3 (SLC43A1) | 8.5 | ||||
LDTP16201 | B-cell receptor-associated protein 29 (BCAP29) | 8.0 |
Transcription factor
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP04454 | Signal transducer and activator of transcription 5B (STAT5B) | . |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP13311 | Poly(U)-binding-splicing factor PUF60 (PUF60) | 16.5 | ||||
LDTP01931 | Keratin, type II cytoskeletal 6A (KRT6A) | 5.0 | ||||
LDTP03865 | Large ribosomal subunit protein uL3 (RPL3) | 5.0 | ||||
LDTP13755 | Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) | 5.0 | ||||
LDTP02030 | Keratin, type II cytoskeletal 6B (KRT6B) | 4.9 | ||||
LDTP11774 | Oxysterol-binding protein-related protein 2 (OSBPL2) | 4.6 | ||||
LDTP10282 | DnaJ homolog subfamily A member 3, mitochondrial (DNAJA3) | 4.5 | ||||
LDTP05002 | Small ribosomal subunit protein eS6 (RPS6) | 4.3 | ||||
LDTP05424 | Keratin, type I cytoskeletal 17 (KRT17) | . | ||||
LDTP08043 | Keratin, type I cytoskeletal 27 (KRT27) | . | ||||
LDTP08138 | Keratin, type II cytoskeletal 1b (KRT77) | . |